Thermo LTQ Orbitrap Velos ETD

Orbitrap ETD

Orbitrap mass analysers are recognised for their ability to produce ultra-high mass accuracy and resolution measurements; these performance capabilities allow mass spectrometry results to be interpreted with a significant degree of confidence.

The Orbitrap Velos ETD is a hybrid instrument that incorporates both Orbitrap and linear ion trap mass analysers; both 1D and 2D nano liquid chromatography (LC) separations can be interfaced to this instrument. This platform allows the benefits of Orbitrap mass analysis to be exploited in highly sensitive experiments.

Detailed insights into analyte molecule structural characteristics can be obtained via tandem and multiple stage mass spectrometry (MS/MS and MSn) experiments, in which various methods of ion activation may be utilised. Analyses are frequently performed upon complex peptide mixtures generated via the enzymatic or chemical hydrolysis of proteins, allowing confident protein identifications to be readily made at low fmol levels.

Quantitative analyses are possible via, for example, the isobaric labelling of peptides. Detailed characterisations of post-translational modifications (PTMs) are capable of being achieved via the various modes of ion activation available during MS/MS. In this regard, subjecting analyte peptides to Electron Transfer Dissociation (ETD) can be particularly useful: labile PTMs are left intact whilst structural information is obtained via peptide bond fragmentation.

Illustrative publications (with DOI Links) involving the Thermo Orbitrap Velos ETD at BMSF:


  1. Wasinger VC; Lu K; Yau YY; Nash J; Lee J; Chang J; Paramsothy S; Kaakoush NO; Mitchell HM; Leong RWL, 2020, 'Spp24 is associated with endocytic signalling, lipid metabolism, and discrimination of tissue integrity for ‘leaky-gut’ in inflammatory bowel disease', Scientific Reports, vol. 10,
  2. Feng X; Bai X; Ni J; Wasinger VC; Beretov J; Zhu Y; Graham P; Li Y, 2019, 'CHTOP in chemoresistant epithelial ovarian cancer: A novel and potential therapeutic target', Frontiers in Oncology, vol. 9,
  3. Wasinger VC; Curnoe D; Bustamante S; Mendoza R; Shoocongdej R; Adler L; Baker A; Chintakanon K; Boel C; Tacon PSC, 2019, 'Analysis of the Preserved Amino Acid Bias in Peptide Profiles of Iron Age Teeth from a Tropical Environment Enable Sexing of Individuals Using Amelogenin MRM', Proteomics, vol. 19, pp. e1800341,
  4. Chang L; Ni J; Beretov J; Wasinger VC; Hao J; Bucci J; Malouf D; Gillatt D; Graham PH; Li Y, 2017, 'Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach', Scientific Reports, vol. 7,
  5. Cochran BJ; Hou L; Manavalan APC; Moore BM; Tabet F; Sultana A; Torres LC; Tang S; Shrestha S; Senanayake P; Patel M; Ryder WJ; Bongers A; Maraninchi M; Wasinger VC; Westerterp M; Tall AR; Barter PJ; Rye KA, 2016, 'Impact of perturbed pancreatic β-cell cholesterol homeostasis on adipose tissue and skeletal muscle metabolism', Diabetes, vol. 65, pp. 3610 - 3620,

Contact People

Dr Valerie Wasinger

Position: Senior Research Scientist
Category: Academic Staff

+61 (2) 9385 1678
+61 (2) 8214 6831